COMMON STOCK PURCHASE WARRANT ATOSSA GENETICS INC.Security Agreement • December 22nd, 2017 • Atossa Genetics Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after June 22, 2018 (the “Initial Exercise Date”) and on or prior to the close of business at 5:00 p.m. (New York City time) on the twelve (12) month anniversary of the Issuance Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Atossa Genetics Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 22nd, 2017 • Atossa Genetics Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 20, 2017, between Atossa Genetics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Mr. Steven C. Quay Chief Executive Officer Atossa Genetics, Inc.Placement Agent Agreement • December 22nd, 2017 • Atossa Genetics Inc • Pharmaceutical preparations • New York
